Authors:
OBRIEN MW
WU A
PUVVALA S
TONG DC
WOOLFENDEN AW
KEMP S
YENARI M
MOSELEY ME
MARKS MP
ALBERS GW
Citation: Mw. Obrien et al., EVOLUTION OF APPARENT DIFFUSION-COEFFICIENT (ADC) OF HUMAN STROKE STUDIED BY SERIAL DIFFUSION-WEIGHTED MAGNETIC-RESONANCE-IMAGING, Stroke, 29(1), 1998, pp. 26-26
Authors:
FINK S
YENARI M
SUN G
CHANG L
PATEL M
KUNIS D
ONLEY D
HO D
SAPOLSKY R
STEINBERG G
Citation: S. Fink et al., OVEREXPRESSION OF HSP72 USING VIRAL VECTORS IMPROVES NEURON SURVIVAL FOLLOWING TRANSIENT FOCAL CEREBRAL-ISCHEMIA AND KAINATE-INDUCED NEUROTOXICITY, Stroke, 29(1), 1998, pp. 47-47
Authors:
OBRIEN MW
ALI J
LANSBERG MG
WU AT
KEMP S
WOOLFENDEN AR
TONG DC
YENARI M
MARKS MP
MOSELEY ME
ALBERS GW
Citation: Mw. Obrien et al., EVOLUTION OF HUMAN CEREBRAL ISCHEMIC LESION VOLUMES AND APPARENT DIFFUSION-COEFFICIENT STUDIED BY SERIAL DIFFUSION-WEIGHTED MAGNETIC-RESONANCE-IMAGING, Neurology, 50(4), 1998, pp. 6091-6091
Authors:
TONG DC
YENARI M
OBRIEN MW
MARKS M
ALBERS GW
MOSELEY ME
Citation: Dc. Tong et al., PERFUSION MRI TIME TO PEAK (TTP) MAP COMPARED WITH DIFFUSION MRI AND CLINICALLY APPARENT NEUROLOGIC DEFICIT IN HYPERACUTE STROKE, Stroke, 28(1), 1997, pp. 60-60
Authors:
YENARI M
KUNIS D
SUN GH
ONLEY D
WU A
COSGROVE S
STEINBERG G
Citation: M. Yenari et al., ANTIBODIES AGAINST THE LEUKOCYTE CD11 CD18 INTEGRIN REDUCES INJURY INA MODEL OF TRANSIENT FOCAL CEREBRAL-ISCHEMIA/, Stroke, 28(1), 1997, pp. 132-132
Authors:
BLACKSHEAR JL
BAKER VS
RUBINO F
SAFFORD R
LANE G
FLIPSE T
MALOUF J
THOMPSON R
WEBEL R
FLAKER GC
YOUNG L
HESS D
FRIEDMAN G
BURGER R
MCANULTY JH
COULL BM
MARCHANT C
TIMBERG J
JANZIK C
GIRAUD G
HALPERIN B
KRON J
WYNN M
RAITT M
ANDERSON DC
ASINGER RW
NEWBURG SM
FIFIELD J
BUNDLIE SR
KOLLER RL
TARREL RD
DICK C
HAUGLAND JM
JORGENSEN CR
LEONARD AD
KANTER MC
SOLOMON DH
ZABALGOITIA M
MEGO D
CARTER JE
BOYD SY
BOOP BS
LALONDE D
MODLIN R
LOGAN WR
GREEN BJ
HAMILTON WP
MEZEI L
RIGGIO S
FELDMAN G
HAYWARD A
STRAUSS R
ANDERSON W
GROVER J
MCKENZIE M
HARTMCARTHUR P
GRAMBERG M
HOUSTON H
HALPERIN JL
ROTHAUF EB
WEINBERGER JM
GOLDMAN ME
LAUPACIS A
CHAN KL
BOURQUE P
BIGGS J
IVES A
FEINBERG WM
KERN KB
PENNOCK GD
FENSTER PE
HUERTA BJ
OHM J
DITTRICH HC
KERRIDGE C
KEEN W
SWENSON M
KOPECKY SL
LITIN SC
WIEBERS DO
HOLLAND AE
BROWN RD
KHANDHERIA BK
MEISSNER I
TUCKER KR
ROTHBART R
TORELLI J
SCHMIDT J
MURRAY D
RUZICH RS
LOUTFI H
APPLETON C
INGALL T
CARLSON L
WILSON D
DUNN M
NOLTE B
EDWARDS C
DICK A
PRICE LA
JANOSIK DL
BJERREGAARD P
QUATTROMANI A
SCHILLER L
LABOVITZ A
BURCH C
PARKS BJ
THOMPSON D
BERARDUCCI L
CAREY S
VIGIL A
FALK R
BATTINELLI N
MCNEIL M
DAVIDOFF R
BERNARD S
BERGETHON P
FIORI L
ALBERS G
ATWOOD E
CLARK J
TONG D
YENARI M
FROELICKER V
LUTSEP H
HOCK NH
QUAGLIETTI S
KEMP S
ALPERT MA
ROTHROCK JF
HUPP CH
MASSEY CV
HAMILTON WJ
MILLER VT
FOX J
Citation: Jl. Blackshear et al., ADJUSTED-DOSE WARFARIN VERSUS LOW-INTENSITY, FIXED-DOSE WARFARIN PLUSASPIRIN FOR HIGH-RISK PATIENTS WITH ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-III RANDOMIZED CLINICAL-TRIAL, Lancet, 348(9028), 1996, pp. 633-638